Farnesoid x receptor modulators
US-2021269475-A1 · Sep 2, 2021 · US
Oxiranes
Oxiranes · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07J71/001 |
| Official title | {Oxiranes} |
| Display label | Oxiranes |
| Total patents | 97 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 8 |
| 2017 | 12 |
| 2018 | 6 |
| 2019 | 14 |
| 2020 | 12 |
| 2021 | 13 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 10 |
| 2025 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Farnesoid x receptor modulators
US-2021228599-A1 · Jul 29, 2021 · US
Compounds for treating neurodegenerative disorders
US-2021079035-A1 · Mar 18, 2021 · US
Neuroactive steriods, compositions, and uses thereof
US-2021061850-A1 · Mar 4, 2021 · US
17-beta-hydroxywithanolides and use thereof in treating cancer
US-2021047363-A1 · Feb 18, 2021 · US
Compositions and methods for treating cns disorders
US-2020392177-A1 · Dec 17, 2020 · US
Neuroactive steroids and compositions thereof
US-2020377547-A1 · Dec 3, 2020 · US
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
US-10849912-B2 · Dec 1, 2020 · US
19-nor neuroactive steroids and methods of use thereof
US-10822370-B2 · Nov 3, 2020 · US
Sustained-release pharmaceutical composition for treatment and prevention of eye disease
US-10808006-B2 · Oct 20, 2020 · US
Withanolides useful for the treatment of neurodegenerative diseases
US-2020325168-A9 · Oct 15, 2020 · US
Complex and structurally diverse compounds
US-10800730-B2 · Oct 13, 2020 · US
Farnesoid x receptor modulators
US-2020297739-A1 · Sep 24, 2020 · US
Neuroactive steroids, compositions, and uses thereof
US-2020165291-A1 · May 28, 2020 · US
Compositions and methods for treating CNS disorders
US-10577390-B2 · Mar 3, 2020 · US
Neuroactive steroids, compositions, and uses thereof
US-2020017542-A1 · Jan 16, 2020 · US
Farnesoid X receptor modulators
US-10532061-B2 · Jan 14, 2020 · US
Taccalonolide microtubule stabilizers
US-10501490-B2 · Dec 10, 2019 · US
Withanolides useful for the treatment of neurodegenerative diseases
US-2019315798-A1 · Oct 17, 2019 · US
Sustained-release pharmaceutical composition for treatment and prevention of eye disease
US-2019233466-A1 · Aug 1, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07J71/001?
- CPC C07J71/001 is the Cooperative Patent Classification code for “Oxiranes.”
- How many patents are filed under CPC C07J71/001 (Oxiranes)?
- Our database includes 97 publications tagged with this CPC code.
- Is patent activity under CPC C07J71/001 growing?
- Publication counts under this code: 10 in 2024 vs 7 in 2025 (latest complete years).